Cargando…

Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection

BACKGROUND: Antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 acute infection has increased. Currently, most of the evidence relates to patients in intensive care units; however, there is little information on patients admitted to hospital wards and there is no consensus protocol o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quiros Ambel, Helena, Crespo-Robledo, Paloma, Arribalzaga Juaristi, Karmele, Plo-Seco, Isabel, Martínez Simón, Jose Javier, Pérez Fernández, Elia, Perez Encinas, Monserrat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523220/ https://www.ncbi.nlm.nih.gov/pubmed/34649964 http://dx.doi.org/10.1136/ejhpharm-2021-002877

Ejemplares similares

Antithrombotic Prophylaxis in the Middle East
por: Arnaout, Samir, et al.
Publicado: (2011)

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
por: Hohaus, Stefan, et al.
Publicado: (2020)

Clinical Utility of Antithrombotic Prophylaxis in ART Procedures: An Italian Experience
por: Grandone, Elvira, et al.
Publicado: (2014)

Cost of incorrect application of antithrombotic prophylaxis prior to invasive procedures
por: Cuevas, Ma Victoria, et al.
Publicado: (2019)

COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis
por: Takasaki, Kazuki, et al.
Publicado: (2021)

Antithrombotic stewardship: a multidisciplinary team approach towards improving antithrombotic therapy outcomes during and after hospitalisation: a study protocol
por: Dreijer, Albert R, et al.
Publicado: (2016)

Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency
por: Artoni, Andrea, et al.
Publicado: (2016)

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis
por: Kessler, Chiara, et al.
Publicado: (2020)

Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
por: Ciavarella, Alessandro, et al.
Publicado: (2020)

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more
por: Connors, Jean M, et al.
Publicado: (2022)

Dry Needling and Antithrombotic Drugs
por: Muñoz, María, et al.
Publicado: (2022)

Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study
por: Ermini, Giuliano, et al.
Publicado: (2017)

Is it time to move to systematic antithrombotic prophylaxis or therapy for all patients with COVID-19 disease?
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2021)

Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer
por: Becattini, Cecilia, et al.
Publicado: (2022)

Is chemical antithrombotic prophylaxis effective in elective thoracolumbar spine surgery? Results of a systematic review
por: Schuster, James M., et al.
Publicado: (2010)

Does antithrombotic prophylaxis worsen early outcomes of total thyroidectomy? - a retrospective cohort study
por: Erdas, E., et al.
Publicado: (2019)

Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery
por: Randelli, F., et al.
Publicado: (2011)

Full versus Baby Dose Aspirin for Antithrombotic Prophylaxis in Free Tissue Transfer: Does Size Matter?
por: Karamanos, Efstathios, et al.
Publicado: (2022)

Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2
por: Carneiro, Jorge David Aivazoglou, et al.
Publicado: (2020)

Antithrombotic prophylaxis in children and adolescent patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians
por: Karimi, Mehran, et al.
Publicado: (2020)

Marine Antithrombotics
por: Dwivedi, Rohini, et al.
Publicado: (2020)

Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options
por: Ay, Cihan, et al.
Publicado: (2017)

Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study
por: Paciullo, Francesco, et al.
Publicado: (2020)

Effects of 120 vs. 60 and 90 g/h Carbohydrate Intake during a Trail Marathon on Neuromuscular Function and High Intensity Run Capacity Recovery
por: Urdampilleta, Aritz, et al.
Publicado: (2020)

Effects of 120 g/h of Carbohydrates Intake during a Mountain Marathon on Exercise-Induced Muscle Damage in Elite Runners
por: Viribay, Aitor, et al.
Publicado: (2020)

Evaluation of antithrombotic prophylaxis and thrombotic events in children with COVID-19 or MIS-C: A tertiary pediatric center experience
por: Guner Ozenen, G., et al.
Publicado: (2023)

Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010)

Antithrombotics in heart failure
por: Miličić, Davor, et al.
Publicado: (2014)

Antithrombotic therapy in TAVI
por: Vavuranakis, Manolis, et al.
Publicado: (2018)

Antithrombotic Agents and Cancer
por: Bruno, Annalisa, et al.
Publicado: (2018)

Monitoring of Antithrombotic Therapy
por: Yamazaki, Masako
Publicado: (2020)

Mauritia flexuosa Presents In Vitro and In Vivo Antiplatelet and Antithrombotic Activities
por: Fuentes, Eduardo, et al.
Publicado: (2013)

Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization
por: Dreijer, Albert R., et al.
Publicado: (2020)

Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study
por: Jochberger, Stefan, et al.
Publicado: (2005)

Late pulmonary embolism in a patient with non-severe COVID-19: case report, value of antithrombotic prophylaxis and literature review
por: Maloumbi, Phany Brunelle Issanga, et al.
Publicado: (2021)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Aneurysmal subarachnoid hemorrhage: factors associated with worse functional outcome
por: Sánchez Montori, L, et al.
Publicado: (2015)

Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain
por: Fortea, José Ignacio, et al.
Publicado: (2020)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Antithrombotic Therapy in Cardiac Embolism
por: Cervera, Álvaro, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_69mjm9a56vglpp6t4g285ogcn3